Retrospective comparison of andexanet alfa and 4-factor prothrombin complex for reversal of factor Xa-inhibitor related bleeding
VM Stevens, TC Trujillo, TH Kiser… - Clinical and Applied …, 2021 - journals.sagepub.com
The aim of this retrospective study was to compare andexanet alfa and 4-factor prothrombin
complex (4F-PCC) for reversal of factor Xa (FXa)-inhibitor bleeding. Patients that received …
complex (4F-PCC) for reversal of factor Xa (FXa)-inhibitor bleeding. Patients that received …